Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kristian Heldal, MD, PhD"'
Autor:
Jørn Petter Lindahl, MD, PhD, Anders Åsberg, MD, PhD, Kristian Heldal, MD, PhD, Trond Jenssen, MD, PhD, Christina Dörje, MD, PhD, Morten Skauby, MD, Karsten Midtvedt, MD, PhD
Publikováno v:
Transplantation Direct, Vol 10, Iss 7, p e1660 (2024)
Background. Transplantation of kidneys from elderly donations after brain death (DBD) donors has increased owing to organ shortages. We aimed to assess the impact on long-term kidney transplant outcomes from DBD donors aged 70 y and older compared wi
Externí odkaz:
https://doaj.org/article/1769bc3fe0a54977a19a459b95a5b505
Autor:
Inga Strand Thorsen, MD, Inger Hjørdis Bleskestad, MD, PhD, Anders Åsberg, PhD, Grete Jonsson, PhD, Øyvind Skadberg, MD, Kristian Heldal, MD, PhD, Lasse Gunnar Gøransson, MD, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 9, p e1522 (2023)
Background. Short-term survival after kidney transplantation is excellent but long-term survival remains suboptimal. The aim of the study was to explore the relationship between soluble α-Klotho (sKlotho) and intact fibroblast growth factor 23 (iFGF
Externí odkaz:
https://doaj.org/article/7e53ece390194932a496d1f60434d218
Autor:
Kjersti Lønning, RN, Msm, Kristian Heldal, MD, PhD, Tomm Bernklev, PhD, Cathrine Brunborg, MSc, Marit Helen Andersen, RN, PhD, Nanna von der Lippe, MD, Anna Varberg Reisæter, MD, PhD, Pål-Dag Line, MD, PhD, Anders Hartmann, MD, PhD, Karsten Midtvedt, MD, PhD
Publikováno v:
Transplantation Direct, Vol 4, Iss 4, p e351 (2018)
Background. We aimed to evaluate changes in health-related quality of life (HRQoL) in patients 65 years or older from time of kidney transplantation (KTx) until 1 year postengraftment. Methods. A single-center prospective study was conducted. HRQoL w
Externí odkaz:
https://doaj.org/article/bd9d2236461e4544a57c737f7f584a61